Teva Initiates Voluntary Nationwide Recall of One Lot of Topotecan Injection 4 mg/4 mL (1 mg/mL) Due to Presence of Particulate Matter | FDA
Generic EpiPen Cleared By FDA As Teva challenges Mylan
ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business
Teva Issues Recall of Tainted Blood Pressure Medicine, the Latest Global Recall for Valsartan | BioSpace
Feds accuse Teva of $300M in kickbacks for MS drug - Drug Discovery and Development
Teva Earns First FDA Approval for Generic Drug for Major Depressive Disorder | 2019-10-10 | FDAnews
Teva Wins FDA Approval for First Viagra Generic, Will Not Launch Until 2017 | RAPS
Teva Receives FDA Approval for Migraine Autoinjector | Ctech
FDA accepts Teva-MedinCell's new drug application for schizophrenia drug
Mylan's fight against Teva highlights logjam created by FDA petitions | Modern Healthcare
FDA approves first generic version of epilepsy drug Sabril from Teva
FDA places hold on Teva, Regeneron back pain trial - PharmaTimes
US FDA nod to Teva for key specialty product to weigh on Sun Pharma | Business Standard News
FDA Warning Letter Reveals Data and Sterility Issues at Teva Plant in Hungary | RAPS
Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of all Amlodipine/Valsartan Combination Tablets and Amlodipine/Valsartan/Hydrochlorothiazide Combination Tablets that are Within Expiry | FDA
Teva recall: Tainted blood pressure drugs continue to show up in U.S. supply | FiercePharma
FDA News Roundup Teva AstraZeneca Amgen Medicines Company And More
Teva Pharmaceuticals USA, Inc. Expands Voluntary Nationwide Recall of Losartan Potassium to 50 mg and 100 mg Tablets USP, Sold Exclusively to Golden State Medical Supply, Inc. | FDA
Israel's Teva on FDA blacklist of drugmakers creating barriers to competition | The Times of Israel
Generic EpiPen Cleared By FDA As Teva Challenges Mylan
Teva faces drug price fixing charges, to cut 350 jobs in Israel; Wintac gets hit by FDA Warning Letter | Radio Compass Blog
Teva Finally Wins FDA Approval for Potential Huntington's Blockbuster Austedo | BioSpace
